Riskpilot← Back to searchSign inGet full accessPeter Olander Holding AB
ABActiveOrg 5567725352Kullasandsliden 2Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20080 employees
Revenue 2024
SEK 0
EBITDA margin
—
0% vs 2023
Equity ratio
96.6%
Financial strength
Net profit 2024
SEK -3K
-100% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -4K | +0% |
| Net profit | SEK -3K | -100% |
| Total assets | SEK 2,1M | -5% |
| Equity | SEK 2M | +0% |
| Employees | 0 | — |
Legal name
Peter Olander Holding AB
Org number
5567725352
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
11 december 2008
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva inköp och försäljning av medicinsk utrustning till offentlig och privat sjukvård samt handel och förvaltning av värdepapper och fastigheter och därmed förenlig verksamhet.
Address
Kullasandsliden 2
Email
peter.olander@po-medica.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 200 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 28 | −3 | −3 | −4 | −4 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 28 | −3 | −3 | −4 | −4 |
| Net financials | 485 | — | 328 | 687 | — |
| Profit before tax | 513 | −3 | 325 | 684 | −3 |
| Tax | −6 | −0 | −0 | −0 | −0 |
| Net profit | 507 | −3 | 325 | 684 | −3 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 617 | 1 334 | 1 555 | 2 154 | 2 055 |
| Equity | 984 | 981 | 1 305 | 1 989 | 1 985 |
| Long-term debt | 550 | 291 | 243 | 159 | 63 |
| Short-term debt | 84 | 62 | 7 | 7 | 7 |
| Total debt | 634 | 353 | 250 | 166 | 70 |
EBITDA margin
-400000.0%
This company
15.8%
Market median
-2531746% vs market
20202024
Equity ratio
96.6%
This company
38.2%
Market median
+153% vs market
20202024
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
20202024
Net profit margin
-300000.0%
This company
8.1%
Market median
-3703804% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JH Audit | Audit | 2022 |
LP Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Peter Olander Holding AB 
P. Olander Medica Försäljning ABBoard members of Peter Olander Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Henrik Johansson | Audit | 0 companies |
| Lars Peter Olander | Chief Executive Officer | 0 companies |
| Ingrid Lena Margareta Olander | Deputy Board Member | 0 companies |